Chen ZS - Search Results

1

Signal processing for neural spike trains.

Berger TW, Chen ZS, Cichocki A, Oweiss KG, Quian Quiroga R, Thakor NV. Berger TW, et al. Among authors: chen zs. Comput Intell Neurosci. 2010;2010:698751. doi: 10.1155/2010/698751. Epub 2010 May 5. Comput Intell Neurosci. 2010. PMID: 20454532 Free PMC article. No abstract available.

2

Modeling and analysis of neural spike trains.

Wu W, Amarasingham A, Chen ZS, Kim SP. Wu W, et al. Among authors: chen zs. Comput Intell Neurosci. 2014;2014:161203. doi: 10.1155/2014/161203. Epub 2014 Jul 3. Comput Intell Neurosci. 2014. PMID: 25104957 Free PMC article. No abstract available.

3

Understanding the Novel Approach of Nanoferroptosis for Cancer Therapy.

Sheikh A, Kesharwani P, Almalki WH, Almujri SS, Dai L, Chen ZS, Sahebkar A, Gao F. Sheikh A, et al. Among authors: chen zs. Nanomicro Lett. 2024 May 2;16(1):188. doi: 10.1007/s40820-024-01399-0. Nanomicro Lett. 2024. PMID: 38698113 Free PMC article. Review.

4

RETRACTED: Ashar et al. Palmitic Acid Impedes Extravillous Trophoblast Activity by Increasing MRP1 Expression and Function. Biomolecules 2022, 12, 1162.

Ashar Y, Teng Q, Wurpel JND, Chen ZS, Reznik SE. Ashar Y, et al. Among authors: chen zs. Biomolecules. 2024 Apr 8;14(4):453. doi: 10.3390/biom14040453. Biomolecules. 2024. PMID: 38672526 Free PMC article.

5

Chemical derivatization leads to the discovery of novel analogs of azotochelin, a natural siderophore, as promising anticancer agents.

Karadkhelkar NM, Gupta P, Barasa L, Chilamakuri R, Hlordzi CK, Acharekar N, Agarwal S, Chen ZS, Yoganathan S. Karadkhelkar NM, et al. Among authors: chen zs. ChemMedChem. 2024 Apr 10:e202300715. doi: 10.1002/cmdc.202300715. Online ahead of print. ChemMedChem. 2024. PMID: 38598189

6

Nanotechnology-based delivery systems to overcome drug resistance in cancer.

Patel H, Li J, Bo L, Mehta R, Ashby CR Jr, Wang S, Cai W, Chen ZS. Patel H, et al. Among authors: chen zs. Med Rev (2021). 2024 Feb 20;4(1):5-30. doi: 10.1515/mr-2023-0058. eCollection 2024 Feb. Med Rev (2021). 2024. PMID: 38515777 Free PMC article. Review.

7

Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiated targeting therapy in hepatocellular carcinoma.

Wang B, Qi FZ, Chen P, Qian LM, Su HS, Wang Y, Wang CH, Hou YX, Zhang Q, Li D, Chen ZS, Zhang SH. Wang B, et al. Among authors: chen zs. Int J Biol Sci. 2024 Feb 11;20(5):1634-1651. doi: 10.7150/ijbs.92211. eCollection 2024. Int J Biol Sci. 2024. PMID: 38481819 Free PMC article.

8

A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple-positive breast cancer.

Huo S, Xue J, Wang S, Shan H, Chen G, Niu N, Wang Y, Qiu F, Zhao Y, Xing F, Zheng X, Tu W, Li K, Zhao H, Tang M, Xu Q, Liu C, Zhao Y, Jiang X, Pang Z, Zhang K, Zhang D, Chen ZS, Liu C. Huo S, et al. Among authors: chen zs. MedComm (2020). 2024 Mar 10;5(3):e505. doi: 10.1002/mco2.505. eCollection 2024 Mar. MedComm (2020). 2024. PMID: 38469548 Free PMC article.

9

Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic stroke.

Li Y, Liao J, Xiong L, Xiao Z, Ye F, Wang Y, Chen T, Huang L, Chen M, Chen ZS, Wang T, Zhang C, Lu Y. Li Y, et al. Among authors: chen zs. J Control Release. 2024 Apr;368:607-622. doi: 10.1016/j.jconrel.2024.02.039. Epub 2024 Mar 15. J Control Release. 2024. PMID: 38423472

10

Combating antimicrobial resistance: the silent war.

Bo L, Sun H, Li YD, Zhu J, Wurpel JND, Lin H, Chen ZS. Bo L, et al. Among authors: chen zs. Front Pharmacol. 2024 Feb 14;15:1347750. doi: 10.3389/fphar.2024.1347750. eCollection 2024. Front Pharmacol. 2024. PMID: 38420197 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

841 results

Search Page